Abstract
SummaryDelayed relief of bladder outflow obstruction has limited the use of laser ablation of the prostate (ELAP). This clinical study was to evaluate the combination of temporary prostatic stenting (a new one size stent) with ELAP in 25 consecutive patients with outflow obstruction, including cases of urinary retention, which might accelerate the time to symptomatic benefit or relief of symptoms. Flow rate, residual volume and symptom score were repeated at 6 weeks. The stent was removed under local anaesthetic at 3 months. Twenty-two of 25 voided immediately post-operatively, including 4 of 5 with previous urinary retention. Early stent migration occurred in one case. Late symptomatic migration was not seen. Mean Qmax improved from 8ml/s to 16.5ml/s at 6 weeks. Voiding scores and residual volumes fell. Previously reported ‘prostatitis’ symptoms were not identified. The use of temporary prostatic stenting enables catheter-free ELAP with early improvement of flow and reduction of voiding score.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Minimally Invasive Therapy & Allied Technologies
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
